Exagamglogene autotemcel

News and Video Search Results

News coverage

Biomay Announces its Successful Support of Approval of First CRISPR/Cas9-based Therapy

Saturday 27 January, 2024- Picture is available at AP -Biomay, a biotech contract development and manufacturing organization based..

Pressat 27 Jan 2024

United States: FDA To Review Vertex Pharmaceutical's Application For CRISPR-Based Gene Therapy Exa-Cel - Goodwin Procter LLP

The Cellular, Tissue, and Gene Therapies Advisory Committee of the FDA is meeting tomorrow, Tuesday, October 31, 2023, to review a..

Mondaq 01 Nov 2023

You might like